David A. Zilberberg

Davis Polk advised the joint lead book-running managers in connection with the $218.8 million public offering of 5,060,000 common shares of TFI International, Inc., which included 660…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Energizer Holdings, Inc. of $600 million aggregate principal amount…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A and Regulation S offering by Spectrum Brands of $300 million aggregate principal amount…

Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Westlake Chemical Corporation of $300 million aggregate principal amount of its 3.375%…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of $1.25 billion aggregate principal amount of its 1.350%…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Veeco Instruments Inc. of an aggregate principal amount of $125 million of…

Davis Polk the initial purchasers in connection with a Rule 144A offering by Cantel Medical Corp. of $140 million principal amount of 3.250% convertible senior notes due 2025. Cantel’s…

Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by E.I. du Pont de Nemours and Company d/b/a Corteva Agriscience, a direct…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Ingredion Incorporated of $600 million aggregate principal amount of 2.900%…